Sham Mailankody, MBBS

About Me

I am a medical oncologist and hematologist specializing in the care of people with multiple myeloma and related plasma cell disorders. With my colleagues at Memorial Sloan Kettering Cancer Center, I am focused on identifying optimal treatment strategies for people with these disorders. I am interested in the molecular pathways underlying progression of plasma cell disorders and the development of targeted strategies aiming to delay, prevent, and cure full-blown disease. I also have an interest in health policy as it relates to oncologic drug approvals and the cost of cancer care.

  • Clinical Expertise: Hematologic Malignancies; Plasma Cell Disorders, including Myeloma, Monoclonal Gammopathies, and Amyloidosis
  • Languages Spoken: English; Hindi; Kannada
  • Education: MBBS, K.S. Hegde Medical Academy
  • Residencies: Internal Medicine - Georgetown University/Washington Hospital Center
  • Fellowships: Medical Oncology - National Cancer Institute
  • Board Certifications: Medical Oncology; Internal Medicine

See My Colleagues


Visit PubMed for a full listing of Sham Mailankody’s journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Clinical Trials

Research is integral to our mission at Memorial Sloan Kettering, and clinical trials help us discover better forms of patient care and treatment. For you, this could mean access to a new therapy or therapy combination. Click to see a list of the trials I’m currently leading.


Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.

Learn more Arrow rightAn icon showing an arrow pointing to the right.